The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Entacapone improves motor fluctuations in levodopa‐ treated Parkinson's disease patients
Abstract
Motor fluctuations associated with levodopa therapy are common problems encountered in the long‐term treatment of Parkinson's disease (PD). Entacapone, a peripherally acting, reversible inhibitor of catechol‐O‐methyltransferase, slows the elimination of levodopa in humans by reducing the formation of 3‐O‐methyldopa. We conducted a placebo‐controlled, double‐blind, parallel‐group, multicenter trial of entacapone in PD patients with motor fluctuations. Two hundred five patients were randomized to receive either entacapone 200 mg or matching placebo with each dose of levodopa and were followed for 24 weeks. The primary measure of efficacy was the change in percentage of “on” time (relief of parkinsonism) while awake, as recorded by subjects at home in diaries completed at 30‐minute intervals. At baseline, patients averaged approximately 10 hours of “on” time per day while awake (60.5% “on” time), and entacapone treatment increased the percent “on” time by 5.0 percentage points. The effect of entacapone was more prominent in patients with a smaller percent “on” time (<55%) at baseline, and increased as the day wore on. Entacapone is effective at increasing the duration of response to levodopa and at relieving parkinsonism in patients experiencing motor flucturations and was well tolerated during the 24 weeks of treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Huynh, H., & Feldt, L. S. (1976) · Journal of Educational Statistics · doi:10.3102/10769986001001069 · Cited by 1,559
Parkinson's Disease and Movement Disorders
Kieburtz, K. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540220013003 · Cited by 616
Nutt, J. G., Woodward, W. R., Beckner, R. M., Stone, C. K., Berggren, K., Carter, J. H., Gancher, S. T., Hammerstad, J. P., & Gordin, A. (1994) · Neurology · doi:10.1212/wnl.44.5.913 · Cited by 247
Kurth, M. C., Adler, C. H., St. Hilaire, M., Singer, C., Waters, C., LeWitt, P., Chernik, D. A., Dorflinger, E. E., & Yoo, K. (1997) · Neurology · doi:10.1212/wnl.48.1.81 · Cited by 205
Olanow, C. W., Fahn, S., Muenter, M., Klawans, H., Hurtig, H., Stern, M., Shoulson, I., Kurlan, R., Grimes, J. D., Jankovic, J., et al. (1994) · Movement Disorders · doi:10.1002/mds.870090107 · Cited by 204
Quantification of neurologic deficit
Wiles, C. M. (1990) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.53.7.628 · Cited by 185
Ruottinen, H., & Rinne, U. K. (1996) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.60.1.36 · Cited by 145
Ker�nen, T., Gordin, A., Karlsson, M., et al. (1994) · European Journal of Clinical Pharmacology · doi:10.1007/bf00199880 · Cited by 127
Kaakkola, S., Teräväinen, H., Ahtila, S., et al. (1994) · Neurology · doi:10.1212/wnl.44.1.77 · Cited by 115
Cited by
Weaver, F. M. (2009) · JAMA · doi:10.1001/jama.2008.929 · Cited by 1,525
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810153391607 · Cited by 1,201
Männistö, P. T., & Kaakkola, S. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01423-6 · Cited by 1,068
The scientific and clinical basis for the treatment of Parkinson disease (2009)
Olanow, C. W., Stern, M. B., & Sethi, K. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a1d44c · Cited by 908
An algorithm (decision tree) for the management of Parkinson’s disease (2001): Treatment Guidelines
Olanow, C. W., Watts, R. L., & Koller, W. C. (2001) · Neurology · doi:10.1212/wnl.56.suppl_5.s1 · Cited by 715
Metadata
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1997-11
- Volume
- 42
- Issue
- 5
- Pages
- 747-755
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W4206634583
- Cited by
- 308
- References
- 13
- FWCI
- 9.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Entacapone improves motor fluctuations in levodopa‐ treated Parkinson's disease patients. https://app.cochat.ai/papers/10.1002/ana.410420511
- The paper
- Entacapone improves motor fluctuations in levodopa‐ treated Parkinson's disease patients. (1997). Annals of Neurology. https://doi.org/10.1002/ana.410420511
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.